Aarti Drugs: Leadership Transition, New Chairman & MD Appointed

Aarti Drugs Ltd. announced a significant leadership transition following a Board Meeting on July 31, 2026. Shri Prakash M. Patil, the current Chairman, Managing Director, and CEO, will retire from his position effective September 30, 2026, citing a desire for early retirement and an orderly leadership transition. He has been associated with the company since its inception. Shri Rashesh C. Gogri, currently the Managing Director, will be elevated to the role of Chairman from October 1, 2026, while retaining his existing MD position. Additionally, Shri Adhish P. Patil, the Chief Financial Officer, will be appointed as the Managing Director for a five-year term, effective October 1, 2026, subject to shareholder approval. The Board also approved the appointment of Shri Nilesh B. Patil as Whole-time Director and the re-appointment of Shri Harshit M. Savla as Joint Managing Director, Shri Harit P. Shah as Whole-time Director, and three Independent Directors (Shri Hasmukh B. Dedhia, Shri Ajit E. Venugopalan, and Shri Sandeep M. Joshi) for second terms.